Mojun Zhu, M.D.

  1. Oncologist

Departments

  1. Oncology (Medical)
  2. Mayo Clinic Comprehensive Cancer Center

Specialty Groups

  1. Early-Onset Colorectal Cancer Group

Location

  1. Phoenix, Arizona | Rochester, Minnesota

Languages

English

Mojun Zhu, M.D., is a medical oncologist with expertise in gastrointestinal cancers. She is passionate about providing individualized, multidisciplinary care to patients with complex malignant conditions and developing better anticancer therapy particularly in the area of immunotherapy. Her research focuses on understanding the interactions between cancer cells and immune cells to identify new combinations of treatment and novel therapeutic targets.

  1. Anal cancer
  2. Cholangiocarcinoma
  3. Colon cancer
  4. Esophageal cancer
  5. Hepatocellular carcinoma
  6. Neuroendocrine tumor
  7. Pancreatic cancer
  8. Rectal cancer
  9. Small bowel cancer
  10. Stomach cancer
  • Gastrointestinal oncology: colorectal cancer
  • Early cancer therapeutics/phase 1 clinical trials
  • Translational research in immuno-oncology
Phx

Phoenix, Arizona
Rochester

Rochester, Minnesota
  1. 2021
    FellowHematology/Oncology, Programs in Rochester, Mayo School of Graduate Medical Education, Mayo Clinic College of Medicine
  2. 2018
    ResidencyYale New Haven Medical Center
  3. 2015
    MDYale University School of Medicine
  4. 2011
    BA - Biology/ChemistryMount Holyoke College

Certifications

  1. 2021
    Medical OncologyAmerican Board of Internal Medicine
  2. 2021
    HematologyAmerican Board of Internal Medicine
  3. 2018
    Internal MedicineAmerican Board of Internal Medicine

Awards and honors

  1. 2020
    Outstanding Fellow AwardMinnesota Society of Oncology
  2. 2020
    Young Investigator AwardAmerican Society of Clinical Oncology
  3. 2018
    Investigation DistinctionYale-New Haven Hospital

Professional memberships

  1. 2019 - present
    MemberSociety for Immunotherapy of Cancer (SITC)
  2. 2018 - present
    MemberAmerican Society of Clinical Oncology
  3. 2018 - present
    MemberAmerican Association of Cancer Research